Nasdaq

Tactile Medical Presents Promising Clinical Data for Flexitouch Plus in Treating Head and Neck Cancer-Related Lymphedema at ASCO 2025 Annual Meeting

Tactile Systems Technology, Inc. announced at the ASCO 2025 Annual Meeting new clinical data showing that its Flexitouch Plus device significantly improves clinical outcomes and quality of life for ...
Nasdaq

Tactile Medical Introduces New ComfortEase™ Flexitouch® Plus Garments and Kylee™ Mobile Application

MINNEAPOLIS, July 25, 2022 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment ...
Seeking Alpha

New Data Demonstrates Significant Clinical and Quality-of-Life Benefits of Flexitouch® Plus in Treating Lymphedema Among Head and Neck Cancer Survivors

MINNEAPOLIS, June 03, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the ...
Business Insider

Tactile Medical Announces Enrollment of First Patient in Randomized, Controlled Clinical Trial Evaluating the Effectiveness of Flexitouch® Plus for the Treatment of Head and ...

Markets Insider and Business Insider Editorial Teams were not involved in the creation of this post. Tactile Systems Technology NewsMORE Related Stocks Indices Commodities Currencies Stocks ...
Star Tribune

NE. Minneapolis medical company now valued at $1B, boasts state's best-performing stock

Veteran CEO Jerry Mattys at Tactile Medical Systems is grateful and takes pride in what the fast-growing northeast Minneapolis company has accomplished since going public in 2016. "I'm delighted with ...